ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,010.00
-100.00 (-4.74%)
At close: Aug 11, 2026
ADBiotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 54,170 | 33,212 | 19,012 | 29,935 | 30,712 | 45,092 | |
Market Cap Growth | 32.35% | 74.69% | -36.49% | -2.53% | -31.89% | 20.26% |
Enterprise Value | 60,933 | 32,727 | 27,330 | 39,459 | 35,183 | - |
Last Close Price | 2010.00 | 2030.00 | 2080.00 | 3275.00 | 3360.00 | 9100.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 11.39 | - |
PS Ratio | 4.33 | 2.58 | 1.71 | 2.86 | 2.89 | 3.81 |
PB Ratio | 3.79 | 2.16 | 3.99 | 2.38 | 1.90 | 8.83 |
P/TBV Ratio | 3.53 | 2.17 | 5.88 | 2.66 | 1.90 | 8.84 |
P/FCF Ratio | - | - | - | 398.99 | - | - |
P/OCF Ratio | 70.67 | - | - | 95.05 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.87 | 2.54 | 2.45 | 3.77 | 3.31 | - |
EV/FCF Ratio | - | - | - | 525.92 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.94 | 1.09 | 2.51 | 1.08 | 0.79 | 2.58 |
Debt / FCF Ratio | - | - | - | 181.40 | - | - |
Net Debt / Equity Ratio | 0.55 | 0.35 | 2.16 | 0.33 | 0.26 | 2.04 |
Net Debt / EBITDA Ratio | -2.28 | -2.10 | -3.33 | -1.15 | -0.97 | -11.50 |
Net Debt / FCF Ratio | -0.52 | -0.31 | -2.40 | 55.93 | -0.44 | -1.81 |
Asset Turnover | 0.37 | 0.36 | 0.44 | 0.35 | 0.41 | 0.60 |
Inventory Turnover | 3.47 | 3.32 | 3.07 | 2.78 | 2.97 | 3.52 |
Quick Ratio | 0.28 | 0.46 | 0.35 | 0.98 | 0.89 | 0.50 |
Current Ratio | 0.49 | 0.70 | 0.62 | 1.19 | 1.20 | 0.69 |
Return on Equity (ROE) | -80.20% | -33.04% | -103.66% | -37.78% | 25.33% | -36.92% |
Return on Assets (ROA) | -8.03% | -6.12% | -10.06% | -10.09% | -11.98% | -4.88% |
Return on Capital Employed (ROCE) | -24.80% | -18.70% | -43.00% | -28.40% | -25.90% | -18.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -15.38% | -9.95% | -41.83% | -9.57% | 8.78% | -5.91% |
FCF Yield | -27.83% | -51.58% | -22.54% | 0.25% | -30.34% | -12.74% |
Buyback Yield / Dilution | -55.08% | -31.40% | 0.00% | 9.33% | -31.17% | -53.77% |